ClariVest Asset Management’s Fate Therapeutics FATE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-11,834
| Closed | -$265K | – | 706 |
|
|
2022
Q3 | $265K | Sell |
11,834
-33
| -0.3% | -$739 | 0.01% | 416 |
|
|
2022
Q2 | $294K | Hold |
11,867
| – | – | 0.01% | 430 |
|
|
2022
Q1 | $460K | Hold |
11,867
| – | – | 0.02% | 401 |
|
|
2021
Q4 | $695K | Sell |
11,867
-721
| -6% | -$42.2K | 0.02% | 384 |
|
|
2021
Q3 | $746K | Sell |
12,588
-458
| -4% | -$27.1K | 0.02% | 366 |
|
|
2021
Q2 | $1.13M | Buy |
13,046
+30
| +0.2% | +$2.6K | 0.04% | 276 |
|
|
2021
Q1 | $1.07M | Sell |
13,016
-800
| -6% | -$66K | 0.04% | 277 |
|
|
2020
Q4 | $1.26M | Sell |
13,816
-18,751
| -58% | -$1.71M | 0.04% | 250 |
|
|
2020
Q3 | $1.3M | Sell |
32,567
-1,476
| -4% | -$59K | 0.04% | 276 |
|
|
2020
Q2 | $1.17M | Buy |
+34,043
| New | +$1.17M | 0.03% | 304 |
|